Skip to main content
. Author manuscript; available in PMC: 2013 Apr 19.
Published in final edited form as: AIDS Care. 2009 Mar;21(3):322–328. doi: 10.1080/09540120802183511

Table 3.

Symptom Frequency and Intensity of Participants by DHHS category and Taking ARVs

Study A Study B

Taking ARVs now CD4 (cells/mm3) – DHHS category N in group % in group Symptom Frequency Mean (0–64) SD Symptom Intensity Mean (0–192) SD N in group % in group Symptom Frequency Mean (0–64) SD Symptom Intensity Mean (0–192) SD
No 0–200 38 21.7% 21.2 20.1 46.2 53.2 29 22.0% 18.7 17.5 40.0 41.1
201–350 22 12.6% 23.8 18.2 37.7 40.7 31 23.4% 20.4 20.2 39.4 33.2
351 and higher 115 65.7% 19.7 19.2 37.0 39.2 72 54.5% 19.3 16.9 37.0 30.7
Total No 175 20.5 19.2 38.5 39.8 132 19.4 17.7 38.2 33.5

Yes 0–200 182 28.2% 19.7 17.0 31.0 29.8 89 25.7% 21.9 17.8 44.4 37.5
201–350 138 21.3% 16.4 15.0 32.5 33.9 70 20.2% 22.2 20.6 43.5 39.7
351 and higher 325 50.3% 17.2 16.0 30.1 30.0 186 19.7% 20.8 18.2 40.6 35.4
Total Yes 645 17.8 16.1 32.2 31.4 345 21.4 18.6 42.2 36.8

Combined 0–200 220 26.8% 19.9 17.5 33.48 34.9 118 24.7% 21.0 17.7 42.9 38.1
201–350 160 19.5% 17.5 15.6 33.22 34.9 101 21.1% 21.7 20.3 42.3 37.5
351 and higher 440 53.7% 17.9 16.9 31.8 32.3 258 54.1% 20.4 17.8 39.8 34.4
Total Combined 820 18.3 16.8 33.7 33.8 477 20.9 18.3 41.1 36.0